Scienture Holdings Inc는 주당 3.0778의 연간 배당금을 지급하며, 수익률은 10.7026%입니다. 배당금은 기타/알 수 없음에 지급되며, 마지막 배당금 지급일은 Jul 19, 2024였습니다.
배당수익률
연간 배당금
배당금 지급일 전일
10.7026%
$3.0778
Jul 19, 2024
지급 빈도
지급 비율
기타/알 수 없음
0.00%
배당금 이력
배당금 지급일 전일
현금 금액
기록 일자
지급일
Jul 19, 2024
$1.50
Jul 19, 2024
Jul 24, 2024
Mar 25, 2024
$8.00
Mar 18, 2024
Mar 22, 2024
배당금 차트
SCNX 배당금
SCNX 배당금 성장률(년간 비교)
Follow-Up Questions
Scienture Holdings Inc의 현재 배당금과 연간 배당금은 얼마인가요?
Scienture Holdings Inc의 배당 성향은 얼마인가요?
SCNX의 배당락일은 언제인가요?
Scienture Holdings Inc은 얼마나 자주 배당금을 지급하나요?
주요 통계
이전 종가
$0.4962
시가
$0.5
일일 범위
$0.48 - $0.5099
52주 범위
$0.461 - $4.5
거래량
859.9K
평균 거래량
21.0M
EPS(TTM)
-1.72
배당수익률
10.70%
시가총액
$20.3M
SCNX란 무엇인가요?
Scienture Holdings, Inc. engages in the provision of health services and pharmaceutical products. The company is headquartered in Commack, New York and currently employs 14 full-time employees. The company went IPO on 2020-02-18. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The firm's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.